Dr Clive Glover, director, Strategy, Pall Corporation discusses recent industry developments surrounding cell and gene therapies and why safety is a key priority for this treatment area.
Dr Clive Glover, director, strategy at Pall Corporation, discusses the steps the pharmaceutical industry has taken to speed up the development of a Covid-19 vaccine.
